Paul Shiu
Rheumatology · San Mateo, CANPI 1508495433
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.1% of the total across 116 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 18.4% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for rheumatology clinicians in CA, where the typical reported total is $1,724.
Across 116 payments — averaging $21.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$462
- Johnson & Johnson$346
- AbbVie$288
- Novartis$233
- Aurinia Pharma U.S., Inc.$190
- UCB, Inc.$175
- plus $814 from 12 others
What the payments were for
- Food & beverage$2,40996%
- Education$994%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 23 | $462 |
| Johnson & Johnson(2 entities) | 14 | $346 |
| AbbVie | 15 | $288 |
| Novartis | 17 | $233 |
| Aurinia Pharma U.S., Inc. | 9 | $190 |
| UCB, Inc. | 7 | $175 |
| AstraZeneca(2 entities) | 6 | $156 |
| Organon | 4 | $125 |
| E.r. Squibb & Sons, L.L.C. | 4 | $86 |
| Pfizer | 3 | $69 |
| Sobi, Inc | 2 | $66 |
| Vertex | 2 | $63 |
| Boehringer Ingelheim | 2 | $62 |
| Sanofi | 2 | $57 |
| ANI Pharmaceuticals, Inc. | 2 | $48 |
| Lilly USA, LLC | 2 | $46 |
| GSK | 1 | $20 |
| Pacira Pharmaceuticals Incorporated | 1 | $17 |
How this compares
$2,508 in reported general payments places this provider in the 50th percentile of 808 rheumatology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MethotrexateMethotrexate Sodium | 52 | $1,197 |
| Mycophenolate Mofetil | 21 | $1,172 |
| Hydroxychloroquine Sulfate | 33 | $1,130 |
| Leflunomide | 23 | $823 |
| Prednisone | 42 | $351 |
| Gabapentin | 12 | $227 |
| Allopurinol | 33 | $180 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in San Mateo
- Rhonda LambertSan Mateo$1.1M
- Bryan GescukSan Mateo$377K
- Sudhakar TumuluriSan Francisco$2.8M
- Ara DikranianSan Diego$2.2M
- Orrin TroumSanta Monica$1.8M
- Robin DoreTustin$1.5M
- Samy MetyasCovina$1.3M
- William ShielMission Viejo$924K
- Mark BoriginiDowney$920K
- Adam KreitenbergTarzana$863K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.